We use cookies to see how investors use El Fondo and make its tools, data and markets better for you. You can accept or reject; essential cookies always stay on. Privacy Policy
Trades about 65% above its sector, the market expects faster growth.
Aarey Drugs & Pharmaceuticals Limited, founded in 1990 and headquartered in Mumbai, India, specializes in the production and distribution of a wide array of chemical substances. The company manufactures active pharmaceutical ingredients (APIs), bulk drugs, chemical intermediates, and specialty chemicals, supplying various industrial sectors throughout India. Its pharmaceutical offerings include key APIs such as metformin HCL, mefenamic acid, and doxophylline, alongside uracile. Additionally, Aarey produces intermediates like mono and dimethyl urea, ortho para nitro anisole, and 2 bromomethyl 1,3 dioxalane. Beyond its core manufacturing, the firm provides a broad spectrum of chemicals and industrial solvents, encompassing aromatics, chemical acids, chlor-alkalies, glycols and glycol ethers, fiber intermediates, acetates and esters, chlorinated solvents, industrial alcohols, ketones, amines, oleochemicals, olefines, phosphates, fertilizers, and monomers. The company's pharmaceutical products are utilized by both pharmaceutical formulation manufacturers and merchant exporters. Furthermore, Aarey Drugs & Pharmaceuticals Limited actively participates in the trading of industrial solvents and other chemicals.
Loading the full price history…
Run your own numbersPast performance is not a forecast.
Save AAREYDRUGS.NS and get told when something moves.
Get updates
A clear, direct weekly summary.
Learn the fundamentals behind this asset.
A stock is a fraction of ownership in a real company. Buy one share and you own a piece (usually a tiny piece) of every desk, factory, contract and brand the company runs. The price moves because the market keeps revising what that whole pie is worth.
The price-to-earnings ratio is how much investors are paying for one dollar of a company's profit. A multiple, never an absolute. Always compared to something: a sector, a region, the company's own past.
Dividend yield is the annual income a stock or ETF pays out, expressed as a percentage of what you paid for it. It is the visible part of total return: the cash that lands in your account every quarter, and the lever most retail investors actually feel.
Market cap is shares times price. A simple formula that produces wildly unequal numbers: a single US tech name can be worth more than every company on a LATAM exchange combined.
